• Latest Posts
In Depth 28 Sep 2023

Obesity drug success sparks biotech buying spree

In Depth 25 Jul 2023

New weight loss drugs: biotech’s mission to end obesity

Fighting obesity with gene therapy

Aspect and Novo Nordisk working on bioprinted tissue for diabetes and obesity

Gut microbiota to be harnessed as a tool to diagnose diseases

Resalis Therapeutics receives €10M to develop obesity and NAFLD treatment